Relative Effectiveness of a High-Dose Quadrivalent Influenza Vaccine versus a Standard-Dose Quadrivalent Influenza Vaccine in Subjects 65 Years of Age and Older
Latest Information Update: 13 Jun 2023
At a glance
- Drugs Influenza virus vaccine (Primary)
- Indications Influenza virus infections
- Focus Adverse reactions; Registrational; Therapeutic Use
- Sponsors Sanofi Pasteur
Most Recent Events
- 06 Oct 2022 Status changed from suspended to discontinued due to COVID-19 pandemic.
- 20 Apr 2022 This trial has been discontinued in Finland, according to European Clinical Trials Database record
- 08 Jun 2021 Status changed from recruiting to suspended due to covid-19.